Pathways for African-Americans' Success (PAAS) for Adolescent Behaviors

Phase-Based Progress Estimates
Adolescent Behaviors+1 More
Pathways for African-Americans' Success (PAAS) - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

This trial will test how an intervention program affects different regions of the brain in order to better prevent or reduce risky behaviors among African-American youth, who are highly vulnerable to the consequences of such behavior.

Eligible Conditions
  • Adolescent Behaviors
  • Risk-Taking

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 3 months post-intervention

3 months post-intervention
Changes in cognitive regulation
Changes in emotional regulation
6 weeks
Changes in fronto-striatal functional connectivity

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Pathways for African-Americans' Success
1 of 2

Active Control

Experimental Treatment

128 Total Participants · 2 Treatment Groups

Primary Treatment: Pathways for African-Americans' Success (PAAS) · No Placebo Group · N/A

Pathways for African-Americans' Success
Experimental Group · 1 Intervention: Pathways for African-Americans' Success (PAAS) · Intervention Types: Behavioral
Wait-listNoIntervention Group · 1 Intervention: Wait-list · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months post-intervention

Who is running the clinical trial?

University of California, IrvineLead Sponsor
497 Previous Clinical Trials
1,879,241 Total Patients Enrolled
Uma Rao, MD5.02 ReviewsPrincipal Investigator - University of California, Irvine
University of California, Irvine
3 Previous Clinical Trials
502 Total Patients Enrolled

Eligibility Criteria

Age < 18 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are of African-American racial status.
Subject and parent/legal guardian agree to participate in the 6-week PAAS program.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: November 30th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.